← Back to Search

Femoral Nerve block for Pain

N/A
Waitlist Available
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks post-operative vs 6 months post-operative
Awards & highlights

Study Summary

All patients over the age of 16 undergoing primary or revision anterior cruciate ligament reconstruction with the use of bone-patellar-bone autograft are eligible for the study. Patients will be randomized pre-operatively to receive either an adductor canal nerve block (single injection) or a femoral nerve block (single injection). Post-operatively, the primary outcome measures of pain level using visual analog scale as well as narcotic and non-narcotic analgesic requirements will be measured.

Eligible Conditions
  • Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks post-operative vs 6 months post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks post-operative vs 6 months post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Narcotic Requirement
Visual Analog Scale
Secondary outcome measures
Straight Leg Raise
Thigh circumference

Trial Design

2Treatment groups
Active Control
Group I: Femoral Nerve blockActive Control1 Intervention
One hour prior to procedure, subject to receive 30 mL of 0.5% ropivacaine injected into the nerve sheath of the femoral nerve at the level of the femoral triangle. Ultrasound guidance utilized for appropriate localization of the targeted nerve sheath for local infiltration. No nerve stimulators to be utilized during or after the procedure.
Group II: Adductor Canal Nerve BlockActive Control1 Intervention
One hour prior to procedure, subject to receive 20 mL of 0.5% ropivacaine injected into the sheath of the saphenous nerve at the adductor hiatus. Ultrasound guidance utilized for appropriate localization of the targeted nerve sheath for local infiltration. No nerve stimulators to be utilized during or after the procedure.

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor
300 Previous Clinical Trials
2,099,921 Total Patients Enrolled
6 Trials studying Pain
362 Patients Enrolled for Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
versusJournal
Adductor Canal Block<i>versus</i>femoral Nerve Block for Total Knee Arthroplasty
Kim, David H., Yi Lin, Enrique A. Goytizolo, Richard L. Kahn, Daniel B. Maalouf, Asha Manohar, Minda L. Patt, et al.. 2014. “Adductor Canal Blockversusfemoral Nerve Block for Total Knee Arthroplasty”. Anesthesiology. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/aln.0000000000000119.
clinicaltrials.govStudy
Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength
Charles S Day 2016. "Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03033589.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top